Live from JPM 2026, a sit-down with Novo Nordisk’s CEO and VC Bob Nelsen - Top-Institutions - MDSpire

Live from JPM 2026, a sit-down with Novo Nordisk’s CEO and VC Bob Nelsen

  • By

  • Allison DeAngelis

  • Adam Feuerstein

  • Elaine Chen

  • January 14, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    Novo Nordisk
    Novo Nordisk

    Bagsværd, Denmark

    Key Differentiators

    • Pharmaceutical R&D
    • Obesity and Metabolic Diseases
    • Biotech Innovation

  • #2

    ARCH Venture Partners
    ARCH Venture Partners

    Chicago, Illinois

    Key Differentiators

    • Venture Capital in Biotech
    • Early-stage Drug Development
    • Biotech Innovation

  • #3

    Massachusetts Institute of Technology (MIT) - Koch Institute for Integrative Cancer Research
    Massachusetts Institute of Technology (MIT) - Koch Institute for Integrative Cancer Research

    Cambridge, Massachusetts

    Key Differentiators

    • Drug Discovery
    • AI in Biomedicine
    • Pharmaceutical Innovation

  • #4

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, California

    Key Differentiators

    • Pharmaceutical R&D
    • Biotech Innovation
    • Metabolic Disease Research

Original Source(s)

Live from JPM 2026, a sit-down with Novo Nordisk’s CEO and VC Bob Nelsen

  • by Allison DeAngelis, Adam Feuerstein, Elaine Chen

  • January 14, 2026

Related Content

Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles

Fresh turmoil at the FDA with Prasad’s exit

Cost-Effectiveness Analysis of a Comprehensive Obesity Prevention Program in Primary Schools in China